ReviewCurrent issues in molecular biology2023

The Current Status and Future Perspectives of Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Endometrial Cancer.

Ji-Young Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.